Description

Pharmacokinetics and Pharmacodynamics:

Montelukast Sodium is a selective leukotriene receptor antagonist that exerts its therapeutic effects by inhibiting the action of leukotrienes, which are inflammatory mediators involved in the pathogenesis of asthma and allergic rhinitis. By blocking the leukotriene receptors, Montelukast Sodium helps reduce airway inflammation, bronchoconstriction, and mucus production, thereby improving respiratory function and symptom control.

Drug Classification:

Montelukast Sodium is classified as a leukotriene receptor antagonist, a class of medications commonly used for the prophylaxis and treatment of asthma and allergic rhinitis. By targeting specific inflammatory pathways in the airways, leukotriene receptor antagonists help alleviate symptoms and improve lung function in patients with respiratory conditions.

Formulations:

Our Montelukast Sodium Range is available in the following formulation:

Montelukast Sodium 4 mg Sachets

Each sachet contains 4 mg of Montelukast Sodium, formulated for convenient administration and accurate dosing. The sachet formulation is ideal for patients who have difficulty swallowing tablets or prefer a more convenient dosage form.

Indications:

Montelukast Sodium sachets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients aged 2 years and older. Additionally, they are indicated for the relief of symptoms of allergic rhinitis, including nasal congestion, sneezing, itching, and rhinorrhea.

Usage:

Montelukast Sodium sachets should be taken orally once daily, with or without food, as directed by a healthcare professional. The contents of the sachet can be mixed with a small amount of soft food or liquid, such as applesauce, yogurt, or water, for ease of administration. It is essential to take Montelukast Sodium regularly to achieve optimal therapeutic benefits and symptom control.

Dosage:

The recommended dosage of Montelukast Sodium for asthma prophylaxis and treatment is as follows:

Adults and adolescents aged 15 years and older: 10 mg once daily

Pediatric patients aged 2 to 14 years: 5 mg once daily

For allergic rhinitis, the recommended dosage is:

Adults and adolescents aged 15 years and older: 10 mg once daily

Pediatric patients aged 6 months to 14 years: 4 mg once daily

Dosage adjustments may be necessary based on individual patient factors and response to treatment. It is important to follow the dosage instructions provided by your healthcare provider for optimal therapeutic outcomes.

Side Effects:

While generally well-tolerated, Montelukast Sodium may cause some side effects, including:

Headache

Abdominal pain

Nausea

Diarrhea

Fatigue

Upper respiratory tract infection

In rare cases, serious side effects such as allergic reactions, neuropsychiatric events, and hepatotoxicity may occur. It is essential to seek medical attention if you experience any unusual or severe symptoms while taking Montelukast Sodium.

Packing Specifications:

Our Montelukast Sodium sachets are meticulously packaged in boxes containing 14 sachets each, providing a convenient and cost-effective solution for respiratory therapy. Each sachet is sealed to maintain product integrity and freshness, ensuring optimal efficacy with every dose.

Trust AIT Pharmaceuticals Division for superior respiratory care and uncompromising quality. With our Montelukast Sodium Range, you can breathe easier and enjoy a better quality of life.